321 related articles for article (PubMed ID: 34392827)
1. COVID-19 associated cranial nerve neuropathy: A systematic review.
Finsterer J; Scorza FA; Scorza C; Fiorini A
Bosn J Basic Med Sci; 2022 Feb; 22(1):39-45. PubMed ID: 34392827
[TBL] [Abstract][Full Text] [Related]
2. [Guillain-Barre syndrome with cranial nerve damage as complication of COVID-19].
Shakaryan AK; Pylaeva SK; Perekopskaya NE; Sayfullin RF; Belyakova AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):100-103. PubMed ID: 34693696
[TBL] [Abstract][Full Text] [Related]
3. [Neuromuscular complications of SARS-CoV-2 infections-Part 1: peripheral nerves].
Lehmann HC; Schoser B; Wunderlich G; Berlit P; Fink GR
Nervenarzt; 2021 Jun; 92(6):540-547. PubMed ID: 33770191
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit.
Finsterer J; Scorza FA; Scorza CA; Fiorini AC
Arq Neuropsiquiatr; 2021 Oct; 79(10):924-928. PubMed ID: 34287509
[TBL] [Abstract][Full Text] [Related]
5. Cranial Nerve Involvement and Dysautonomia in Post-COVID-19 Guillain-Barré Syndrome.
Kakumoto T; Kobayashi S; Yuuki H; Kainaga M; Shirota Y; Hamada M; Hashimoto Maeda M; Kubota A; Kawai M; Saito M; Ishiura H; Toda T
Intern Med; 2021 Nov; 60(21):3477-3480. PubMed ID: 34433712
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports.
Zuberbühler P; Conti ME; León-Cejas L; Maximiliano-González F; Bonardo P; Miquelini A; Halfon J; Martínez J; Gutiérrez MV; Reisin R
Rev Neurol; 2021 Mar; 72(6):203-212. PubMed ID: 33710610
[TBL] [Abstract][Full Text] [Related]
7. Is facial nerve palsy an early manifestation of COVID-19? A literature review.
Estakhr M; Tabrizi R; Ghotbi Z; Shahabi S; Habibzadeh A; Bashi A; Borhani-Haghighi A
Am J Med Sci; 2022 Sep; 364(3):264-273. PubMed ID: 35429449
[TBL] [Abstract][Full Text] [Related]
8. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
Dang YL; Bryson A
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of Guillain Barre syndrome.
Dhadke SV; Dhadke VN; Bangar SS; Korade MB
J Assoc Physicians India; 2013 Mar; 61(3):168-72. PubMed ID: 24475678
[TBL] [Abstract][Full Text] [Related]
11. [Ophthalmic manifestations in COVID-19-associated multiple mononeuropathy of the cranial nerves (clinical observation)].
Grusha YO; Maksimova MY; Fettser EI
Vestn Oftalmol; 2022; 138(5):94-98. PubMed ID: 36288423
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Guillain-Barré Syndrome post COVID-19: a systematic review of case reports and case series.
Mahmoud H; Alhathla A; El-Fiky A; Alghamdi MS; Alwafi R; El-Sayed MS; Thabet AA; Alkhateeb AM; Elgendy SR; Hegazy R; Darweesh A
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2152-2164. PubMed ID: 36930515
[TBL] [Abstract][Full Text] [Related]
13. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular presentations in patients with COVID-19.
Paliwal VK; Garg RK; Gupta A; Tejan N
Neurol Sci; 2020 Nov; 41(11):3039-3056. PubMed ID: 32935156
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of Acute Neuropathy Associated With Covid-19: A Clinical and Electrophysiological Study of 13 Patients From a Single Center.
Yaranagula SD; Koduri VKC
Int J Infect Dis; 2021 Sep; 110():314-319. PubMed ID: 34333121
[TBL] [Abstract][Full Text] [Related]
16. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019.
Yakoby J; Litvak I; Yu E
J Emerg Med; 2021 Oct; 61(4):e67-e70. PubMed ID: 34103203
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
[TBL] [Abstract][Full Text] [Related]
19. Multiple cranial neuropathy variant of Guillain-Barré syndrome: a case series.
Wang Q; Xiang Y; Yu K; Li C; Wang J; Xiao L
Muscle Nerve; 2011 Aug; 44(2):252-7. PubMed ID: 21698648
[TBL] [Abstract][Full Text] [Related]
20. Authors' Reply to: "Affection of Cranial Nerves in COVID-19 Patients Should Prompt Suspicion of Guillain-Barré Syndrome".
Decavel P; Nahmias O; Petit C; Tatu L
Eur Neurol; 2022; 85(3):210-211. PubMed ID: 35104817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
